Brain organoids and other non-animal models (NAMs) have created new opportunities to study brain development and disease as well as to evaluate potential therapeutics in biologically relevant systems. There are, however, still challenges with variability in organoid generation, reagents, culture conditions, and analytical methods that limit reproducibility, standardization, and broader adoption. Furthermore, complex, labor-intensive workflows can also create operational challenges when researchers attempt to increase throughput or scale production for larger studies.

In this GEN webinar, our expert panelists will discuss some of the scientific and practical barriers that are facing brain organoid research and strategies for improving organoid-to-organoid and experiment-to-experiment consistency. During the conversation, they will offer strategies for managing reagent and vendor variability, simplifying multi-step workflows, and selecting appropriate controls and analytical methods. They will also discuss emerging culture systems, automation and analysis technologies, and ways to support more standardized, scalable, and reliable applications of brain organoids.

A live Q&A session will follow the presentation offering you a chance to pose questions to our expert panelists.

Produced with support from: